Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma



      To compare primary selective laser trabeculoplasty (SLT) response in uveitic, steroid-induced, primary open-angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEX).


      Single-centre retrospective case–control study.


      Patients with uveitic glaucoma, steroid-induced glaucoma, POAG, or PEX who had their first SLT.


      Eyes with POAG or PEX were in control groups. Eyes with steroid-induced or uveitic glaucoma were in experimental groups. Change in intraocular pressure from baseline, treatment failure, complication rates, and medication use were compared using rank-sum and log-rank tests.


      Six-hundred and eight eyes of 433 patients were enrolled. Steroid-induced glaucoma eyes had higher mean baseline pressure and a decrease in pressure at 3–8 weeks (27.6–17.4 mm Hg) than those with PEX (21.7–16.5 mm Hg; p < 0.001) or POAG (18.6–14.9 mm Hg; p ≤ 0.025). Failure rates after 2 years were lower in steroid-induced glaucoma (54%) than in PEX (84%; p = 0.01) or POAG (84%; p = 0.005). This survival benefit persisted when excluding patients with changes to their steroid dosing (p ≤ 0.03) but showed mixed results when compared with patients with a baseline pressure of 25mm Hg or greater (p = 0.020 vs PEX; p = 0.67 vs POAG). At 18 months, the steroid-induced group decreased ocular hypotensive medication use (3.5–1.9; p = 0.005); the uveitic group increased medication use (2.7–3.5; p = 0.02).


      SLT is an effective treatment for steroid-induced glaucoma, with greater response and a lower failure rate than in PEX and primary POAG, although high baseline intraocular pressure may be a confounder. Judicious use of SLT can be considered in uveitic glaucoma.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Baser E
        • Seymenoglu R.
        Selective laser trabeculoplasty for the treatment of intraocular pressure elevation after intravitreal triamcinolone injection.
        Can J Ophthalmol. 2009; 44: e21
        • Bozkurt E
        • Kara N
        • Yazici AT
        • et al.
        Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
        Am J Ophthalmol. 2011; 152 (976–81.e972)
        • Pizzimenti JJ
        • Nickerson MM
        • Pizzimenti CE
        • Kasten-Aker AG.
        Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
        Optom Vis Sci. 2006; 83: 421-425
        • Rubin B
        • Taglienti A
        • Rothman RF
        • Marcus CH
        • Serle JB.
        The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
        J Glaucoma. 2008; 17: 287-292
        • Yuki K
        • Inoue M
        • Shiba D
        • Kawamura R
        • Ishida S
        • Ohtake Y.
        Selective laser trabeculoplasty for elevated intraocular pressure following subtenon injection of triamcinolone acetonide.
        Clin Ophthalmol. 2010; 4: 247-249
        • Wong MO
        • Lee JW
        • Choy BN
        • Chan JC
        • Lai JS.
        Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma.
        Surv Ophthalmol. 2015; 60: 36-50
        • Tokuda N
        • Inoue J
        • Yamazaki I
        • et al.
        [Effects of selective laser trabeculoplasty treatment in steroid-induced glaucoma].
        Nippon Ganka Gakkai Zasshi. 2012; 116: 751-757
        • Siddique SS
        • Suelves AM
        • Baheti U
        • Foster CS
        Glaucoma and uveitis.
        Surv Ophthalmol. 2013; 58: 1-10
        • Cubey RB.
        Glaucoma following the application of corticosteroid to the skin of the eyelids.
        Br J Dermatol. 1976; 95: 207-208
        • Smith S
        • Lorenz D
        • Peace J
        • McLeod K
        • Crockett RS
        • Vogel R.
        Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery.
        Clin Ophthalmol. 2010; 4: 983-991
        • Zugerman C
        • Saunders D
        • Levit F.
        Glaucoma from topically applied steroids.
        Arch Dermatol. 1976; 112: 1326
        • Alvarado JA
        • Alvarado RG
        • Yeh RF
        • Franse-Carman L
        • Marcellino GR
        • Brownstein MJ.
        A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells.
        Br J Ophthalmol. 2005; 89: 1500-1505
        • Alvarado JA
        • Chau P
        • Wu J
        • Juster R
        • Shifera AS
        • Geske M.
        Profiling of cytokines secreted by conventional aqueous outflow pathway endothelial cells activated in vitro and ex vivo with laser irradiation.
        Invest Ophthalmol Vis Sci. 2015; 56: 7100-7108
        • Alvarado JA
        • Yeh RF
        • Franse-Carman L
        • Marcellino G
        • Brownstein MJ.
        Interactions between endothelia of the trabecular meshwork and of Schlemm's canal: a new insight into the regulation of aqueous outflow in the eye.
        Trans Am Ophthalmol Soc. 2005; 103 (discussion, 162–3): 148-162
        • Lee JY
        • Kagan DB
        • Roumeliotis G
        • Liu H
        • Hutnik CM.
        Secretion of matrix metalloproteinase-3 by co-cultured pigmented and non-pigmented human trabecular meshwork cells following selective laser trabeculoplasty.
        Clin Exp Ophthalmol. 2016; 44: 33-42
        • Tane N
        • Dhar S
        • Roy S
        • Pinheiro A
        • Ohira A
        • Roy S.
        Effect of excess synthesis of extracellular matrix components by trabecular meshwork cells: possible consequence on aqueous outflow.
        Exp Eye Res. 2007; 84: 832-842
        • Dang Y
        • Kaplowitz K
        • Parikh HA
        • et al.
        Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma.
        Clin Exp Ophthalmol. 2016; 44: 783-788
        • Choi EY
        • Walton DS.
        Goniotomy for steroid-induced glaucoma: clinical and tonographic evidence to support therapeutic goniotomy.
        J Pediatr Ophthalmol Strabismus. 2015; 52: 183-188
        • Sung VC
        • Barton K.
        Management of inflammatory glaucomas.
        Curr Opin Ophthalmol. 2004; 15: 136-140
        • Martow E
        • Hutnik CM
        • Mao A.
        SLT and adjunctive medical therapy: a prediction rule analysis.
        J Glaucoma. 2011; 20: 266-270
        • Hodge WG
        • Damji KF
        • Rock W
        • Buhrmann R
        • Bovell AM
        • Pan Y.
        Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial.
        Br J Ophthalmol. 2005; 89: 1157-1160
        • Kersey JP
        • Broadway DC.
        Corticosteroid-induced glaucoma: a review of the literature.
        Eye (Lond). 2006; 20: 407-416